The new crown vaccine should be given priority to specific populations

WHO Director-General Tan Desser said on the 4th, the future of the new crown vaccine officially put into use, due to the limited initial supply, the first task is to vaccinate specific populations in all countries, not all people in some countries.'We all hope that there will be good news about the new crown vaccine in the coming months, ' Mr. Tandese said at a regular press conference that day. Once safe and effective vaccines are available, initial availability should be limited, so priority must be given to inoculation of practitioners and high-risk groups in key sectors, including the elderly and people with underlying diseases. This is necessary not only in moral and public health responsibilities, but also economically. In the future, as vaccine production increases, everyone will have access to vaccinations.There are currently nine new crown candidate vaccines supported by the Alliance for Innovation in Epidemiology Prevention (CEPI), seven of which are in clinical trials and, if successful, will be incorporated into the COVAX Global Vaccine Mechanism, Tandese said. In addition, WHO is discussing four promising vaccine candidates and assessing whether to include the other nine vaccine candidates, which are still in the early stages of development, in COVAX. Tanderser said 78 middle- and high-income countries and economies have confirmed they will join COVAX, and the number is growing.Sumia Swaminathan, WHO's chief scientist, said the new crown vaccine was still in its early stages of development and needed to be tested several days. It is expected that by mid-2021, the new crown vaccine will begin to enter countries. (Xinhua) --